Interferon alfa-2b in renal transplant recipients with viral chronic hepatitis: A pilot study

被引：0
|
作者：
Monteon, FJ
Contreras, AM
Espinoza, L
Vazquez, G
Aguilar, S
Cueva, L
机构：
[1] HOSP ESPECIALIDADES CTR MED LA RAZA,CTR MED OCCIDENTE,INST MEXICANO SEGURO SOCIAL,DEPT NEPHROL,GUADALAJARA,JALISCO,MEXICO
[2] HOSP ESPECIALIDADES CTR MED LA RAZA,CTR MED OCCIDENTE,INST MEXICANO SEGURO SOCIAL,GUADALAJARA,JALISCO,MEXICO
[3] HOSP ESPECIALIDADES CTR MED LA RAZA,CTR MED OCCIDENTE,INST MEXICANO SEGURO SOCIAL,GUADALAJARA,JALISCO,MEXICO
[4] HOSP ESPECIALIDADES CTR MED LA RAZA,CTR MED OCCIDENTE,INST MEXICANO SEGURO SOCIAL,DEPT PATHOL,GUADALAJARA,JALISCO,MEXICO
[5] HOSP ESPECIALIDADES CTR MED LA RAZA,CTR MED OCCIDENTE,INST MEXICANO SEGURO SOCIAL,DEPT MICROBIOL,GUADALAJARA,JALISCO,MEXICO
来源：
TRANSPLANTATION PROCEEDINGS | 1996年 / 28卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：3306 / 3308
页数：3
相关论文
共 50 条
  • [41] Sustained antiviral response with consensus interferon (CIFN)plus ribavirin or interferon alfa-2b (IFN alfa-2b) plus ribavirin in treatment-naive subjects with chronic hepatitis C. A pilot study.
    Sjogren, MH
    Holtzmuller, K
    Smith, M
    Sjogren, R
    HEPATOLOGY, 2002, 36 (04) : 311A - 311A
  • [42] Comparison of pegylated interferon alfa-2a and alfa-2b in combination with ribavirin in obese patients with chronic hepatitis
    Moore, CH
    Angtuaco, TL
    Lindsey, JL
    Nelson, SD
    Malik, AH
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S109 - S109
  • [43] r-interferon alfa-2b/ribavirin combined therapy followed by low-dose r-interferon alfa-2b in chronic hepatitis C interferon nonresponders
    Perasso, A
    Testino, G
    Ansaldi, F
    Venturino, V
    Icardi, GC
    HEPATOLOGY, 1999, 29 (01) : 297 - 298
  • [44] Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B
    Huang, Yi-Wen
    Hsu, Chao-Wei
    Lu, Sheng-Nan
    Yu, Ming-Lung
    Su, Chien-Wei
    Su, Wei-Wen
    Chien, Rong-Nan
    Hsu, Ching-Sheng
    Hsu, Shih-Jer
    Lai, Hsueh-Chou
    Qin, Albert
    Tseng, Kuan-Chiao
    Chen, Pei-Jer
    HEPATOLOGY INTERNATIONAL, 2020, 14 (06) : 997 - 1008
  • [45] INTERFERON ALFA-2B IN THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA
    NIEDERLE, N
    KLOKE, O
    OSIEKA, R
    WANDL, U
    OPALKA, B
    SCHMIDT, CG
    SEMINARS IN ONCOLOGY, 1987, 14 (02) : 29 - 35
  • [46] Long-term response to interferon alfa-2b in chronic hepatitis C.
    Kuziemski, A
    Topczewska-Staubach, E
    Pawlowska, M
    Olczak, A
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 428 - 428
  • [47] Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy
    Kraus, MR
    Schäfer, A
    Faller, H
    Csef, H
    Scheurlen, M
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (06) : 708 - 714
  • [48] Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
    Davis, GL
    Esteban-Mur, R
    Rustgi, V
    Hoefs, J
    Gordon, SC
    Trepo, C
    Shiffman, ML
    Zeuzem, S
    Craxi, A
    Ling, MH
    Albrecht, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21): : 1493 - 1499
  • [49] Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B
    Yi-Wen Huang
    Chao-Wei Hsu
    Sheng-Nan Lu
    Ming-Lung Yu
    Chien-Wei Su
    Wei-Wen Su
    Rong-Nan Chien
    Ching-Sheng Hsu
    Shih-Jer Hsu
    Hsueh-Chou Lai
    Albert Qin
    Kuan-Chiao Tseng
    Pei-Jer Chen
    Hepatology International, 2020, 14 : 997 - 1008
  • [50] Pegylated interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C genotype
    Hasan, F
    Asker, H
    Al-Khaldi, J
    Siddique, I
    Owaid, SF
    Al-Ajmi, M
    Al-Nakib, B
    HEPATOLOGY, 2003, 38 (04) : 629A - 629A
12345